GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
X

Xvivo Perfusion XVIVO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

200.80

+1.67%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on Xvivo Perfusion

Our reporting

Next results

28 Jan 2027

Due on 28 Jan 2027. Analysts expect earnings of 0.87 a share on revenue of SEK 261.6m.

Past results

Reported against what analysts expected

22 Oct 202614 Jul 202624 Apr 202627 Jan 202623 Oct 202511 Jul 2025
Earnings per share1.390.651.151.050.260.05
Forecast0.640.750.940.680.440.62
RevenueSEK 249.1mSEK 239.0mSEK 241.0mSEK 226.0mSEK 189.0mSEK 178.2m
ForecastSEK 235.9mSEK 235.7mSEK 235.9mSEK 214.1mSEK 214.1mSEK 218.1m

Key events

  1. 8 Oct 2012Listed

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.